The agreement, which officials from both institutions announced Sept. 15, will align Duke School of Medicine’s Clinical & Translational Science Institute with NCCU’s Biomanufacturing Research Institute and Technology Enterprise.
The goal of the collaboration is to combine research initiatives at both facilities to improve drug development and understand the proliferation of certain diseases.
The universities also plan to create a degree-supplement certificate for NCCU students to gain experience conducting clinical research. While details regarding the program have not been released, a committee comprising Duke and NCCU representatives will plan the program’s curriculum, the report states.
The institutions will also reportedly offer internships to select Duke students who earn the certificate.
More articles on hospital-physician relationships:
LA Times publishes photos of former USC Keck medical school dean allegedly engaging in drug misuse
UPMC fires several employees after they ogled, photographed anesthetized patient with genital injury
Emory University names Dr. Vikas Sukhatme dean of medical school
